Navigation Links
Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
Date:7/30/2008

P>

This Company's Blue print for operation is to deploy a "zero waste" municipal solid waste treatment alternative using the Biosphere process. This Biosphere Technology meets and exceeds all international environment requirements in any jurisdiction.

A Biosphere is a gasification process was developed by Dr. Chris McCormack, of Global Environmental Energy Corporation (GEECF) (www.geecf.ru). The process begins with waste delivered to the Biosphere Chamber, being converted into clean combustible gas. This end-product is used to produce electricity in a combined cycle gas/steam turbine. Heat generated by the system can be used to produce electricity, superheat steam, heat boiler water, and distil/desalinate seawater. This proven technology can eliminate solid and liquid waste, reduce current landfill volume by about 95 percent; recover brown landfill site for development; generate 5 to 7 megawatts of continuous power/hour; distil up to 53,000 gallons of drinking water per unit per hour and produce inert ash to be sold to the commercial and industrial market.

Global is a fully integrated energy company whose interests include electrical power generation, oil and gas exploration and production, clean coal and waste management technologies.

This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of the 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe Harbor created by those sections.

(Ruth P. Briones, Philippines, www.spectrumbluesteel.com).

# # #

Read the full story at http://www.prweb.com/releases/2008/07/prweb1162674.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. "Brave New Reality" Provides a Wide Spectrum of High Tech News and Easy Science.
2. Spectrum Blue Steel's fresh foreign investment at 18 Billion and the Biosphere process spark attention on a global scale
3. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
4. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
5. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
6. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
7. Global Experts Explore Entire Spectrum of Aids Vaccine Development
8. U-M research: New plastic is strong as steel, transparent
9. Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide
10. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
11. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... new study led by George Washington University Professor ... of ice in small droplets is strongly size-dependent, ... the nanoscale. The formation of ice at the ... whose answer also has important implications for climate ... of ice from supercooled water is generally initiated ...
(Date:5/21/2013)... , May 21, 2013 ... Dialysis and Transplant Association) is the biggest congress in ... replacement therapy. Nearly 10,000 participants are in ... the latest research findings. New pioneering studies have been ... "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA ...
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... 21, 2013 According to a ... http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, Reagents, ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market ... is expected to grow at a CAGR of 10.1% ... of USD 4.7 billion in 2018. Browse ...
Breaking Biology Technology:Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5
... China, May 14 Simcere Pharmaceutical,Group (NYSE: SCR ), ... of the patented anti-cancer biotech,product Endu in China, today announced ... conferences:, * Brean Murray Carret & Co. ... Waldorf-Astoria in New York on Monday, May 19, 2008 at ...
... 14 SynCo Bio Partners B.V., a leading,GMP ... manufacture and release of ActoGeniX, drug substance AG011 ... ulcerative colitis patients., ActoGeniX is focused on ... of protein-based biopharmaceuticals that can,be orally administered. The ...
... CITY, New Jersey, May 14, Rosetta Genomics (Nasdaq: ... results on May 21, 2008, before the,U.S. markets open. ... webcast to discuss these results at 4:30 p.m. ET ... call, U.S. and Canadian participants may,dial +1-866-966-5335; international participants ...
Cached Biology Technology:Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 3Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results 2
(Date:5/21/2013)... of all types become most deadly when they metastasize ... reached this stage, it becomes very difficult for doctors ... develop. Now, researchers at the University of Missouri have ... lymphoma tumor cells wherever they may be in the ... the MU College of Veterinary Medicine, says being able ...
(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... genes function without changing the underlying DNA sequence, ... pregnant women during any trimester, potentially providing a ... after giving birth, and an opportunity to intervene ... the small study involving 52 pregnant women are ... . , "Postpartum depression can be harmful to ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... small biotech company in Boulder, CO, announced today that they ... The FluChip was invented by a joint team of ... Disease Control and Prevention in an NIH sponsored effort led ... CEO of InDevR, said that InDevR has arranged to test ...
... grants totaling $24 million in U.S. dollars have ... hospitals to fund studies related to asthma and ... cancer. The extramural grants were awarded by ... for Science, Technology and Research), the government agency ...
... The Entomological Society of America (ESA) will feature ... Meeting in Indianapolis, December 13-16, 2009. Integrative ... Cold Case Files: Integrative Perspectives on Physiological ... Evolutionary Arms Race of Resistance in Herbivores ...
Cached Biology News:FluChip technology licensed to combat deadly flu virus 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 3Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 4Symposia selected for Entomological Society of America meeting 2Symposia selected for Entomological Society of America meeting 3Symposia selected for Entomological Society of America meeting 4
... Magnetofection technology, SilenceMag is the most ... rapid and easy to use, SilenceMag ... Specifically designed for siRNA delivery, SilenceMag ... low doses of siRNA.,SilenceMag formulation gives ...
... Last innovation from Magnetofection technology, SilenceMag ... system available. Simple, rapid and easy ... and non toxic. Specifically designed for ... silencing at very low doses of ...
... 4 H 10 O 2 S ... SPECIFICATIONS Form: White crystalline powder Assay: ... Identity: By IR Melting Point: greater ... DTT: less than or equal to ...
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
Biology Products: